chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Arm hurt after second dose; Tired; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Arm hurt after second dose) and FATIGUE (Tired) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 025B21A and 030A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced PAIN IN EXTREMITY (Arm hurt after second dose) and FATIGUE (Tired). At the time of the report, PAIN IN EXTREMITY (Arm hurt after second dose) and FATIGUE (Tired) outcome was unknown. Not Provided          no concomitant medications are provided. Action taken with mRNA-1273 in response to the event was not applicable
2 days later, developed rash on the abdomen, both arms; redness at the injection site.; This spontaneous case was reported by a health care professional and describes the occurrence of RASH (2 days later, developed rash on the abdomen, both arms) and INJECTION SITE ERYTHEMA (redness at the injection site.) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 29L20A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced RASH (2 days later, developed rash on the abdomen, both arms) and INJECTION SITE ERYTHEMA (redness at the injection site.). At the time of the report, RASH (2 days later, developed rash on the abdomen, both arms) and INJECTION SITE ERYTHEMA (redness at the injection site.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported. Action taken with mRNA-1273 in response to the event was not applicable.
Starting around 09/25/2022, I started noticing a numbness in my feet. Since then, it has progressed slightly to my hands. Now, the bottoms of my feet don't feel normal (the sensation isn't totally there). I tend to notice it more in the evening when I am not doing as much. Also, I have had tingling in my hands, feet and legs more noticeably at night time. Last time I saw my rheumatologist (10/19), they had seen progression in my arthritis, which had been stable for quite a few years before having the vaccines.
Fatigue, Hard swelling, throat tightness apprx. 6 hours after administration.
I was sick; This case was reported by a consumer via interactive digital media and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was unknown.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 18-Jun-2022 Reporter's comments: This case was reported by patient via interactive digital media. The patient got the first shot and was sick when it was time to get the second one and was not sure what to do now. Additional Supportive Information: The incomplete course of vaccination was not considered as patient was sick when it was time to get 2nd dose.
A nurse reported the occurrence of injection site cellulitis in a 16-month-old subject of unspecified gender who was vaccinated with diphtheria and tetanus toxoids and acellular pertussis vaccine adsorbed (Infanrix) for prophylaxis.  The subject's relevant medical history, concurrent conditions, and concurrent medications were unknown.  On 02/11/2003, the subject received an Infanrix injection (lot DTPA578A9).  Subsequently, the subject experienced injection site cellulitis; the diagnosis was made by the vaccine provider.  The reporting nurse did not know if the vaccine provider had examined the subject or prescribed any medicine.  The reporting nurse stated that the event was possibly related to Infanrix administration.  As of 02/18/2003, the outcome of the event was unknown.  Comment:  This is one of five subjects, out of 19 children immunized, who developed injection site cellulitis following receipt of Infanrix lot DTPA578A9.  Please see reports A039719A, A0398143A, A0398144A, and A0398146A.
Vaccine was expired on 15-Sep-2022, the vial was initially stored in the refrigerator on 20-Sep-2022; No adverse event; accidentally administered a patient with an expired dose of the Moderna Covid 19 vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (accidentally administered a patient with an expired dose of the Moderna Covid 19 vaccine), PRODUCT STORAGE ERROR (Vaccine was expired on 15-Sep-2022, the vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event) in a 26-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch nos. 006M21A and 006M21A) for an unknown indication.     The patient had no allergies The patient never tested positive to COVID 19.    On 19-Aug-2022, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 20-Sep-2022, received second dose of mRNA-1273 (Spikevax) (unknown route) dosage was changed to 1 dosage form. On 20-Sep-2022,  after starting mRNA-1273 (Spikevax), the patient experienced EXPIRED PRODUCT ADMINISTERED (accidentally administered a patient with an expired dose of the Moderna Covid 19 vaccine). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine was expired on 15-Sep-2022, the vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (accidentally administered a patient with an expired dose of the Moderna Covid 19 vaccine), PRODUCT STORAGE ERROR (Vaccine was expired on 15-Sep-2022, the vial was initially stored in the refrigerator on 20-Sep-2022) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessments were provided for EXPIRED PRODUCT ADMINISTERED (accidentally administered a patient with an expired dose of the Moderna Covid 19 vaccine) and PRODUCT STORAGE ERROR (Vaccine was expired on 15-Sep-2022, the vial was initially stored in the refrigerator on 20-Sep-2022).    The patient was not taking any concomitant medication. It was reported that Individual vial with 5.5 ml size. The vial did not undergo any temperature excursions. No treatment drug was reported.
Pt came in as a walk in for his second dose and it was missed that he was a week early for his vaccine, the mistake was caught after the patient left and the vaccine was been documented. His first vaccine was given on 04/12/2021 and he was due for his second dose on 05/10/2021. We contacted Moderna and we are waiting for further instructions, also patient was notified.
Facial swelling, rash on face, knees, and top of feet starting 2 hours post vaccine, subsiding over the course of 8 hours with ongoing mild facial rash
WAS NERVOUS BEFORE GETTING INJECTION- BECAME DIZZY AND NAUSEATED IMMEDIATELY AFTER INJECTION GIVEN-RECOVERD IN 10 MINS.
Expired vaccine administered/Vaccine administered after it was expired; Vaccine taken out of Fridge drawn up and put back, syringe was given chance to warm up a bit; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered/Vaccine administered after it was expired) and PRODUCT STORAGE ERROR (Vaccine taken out of Fridge drawn up and put back, syringe was given chance to warm up a bit) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006D21A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered/Vaccine administered after it was expired) and PRODUCT STORAGE ERROR (Vaccine taken out of Fridge drawn up and put back, syringe was given chance to warm up a bit). On 06-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine administered/Vaccine administered after it was expired) and PRODUCT STORAGE ERROR (Vaccine taken out of Fridge drawn up and put back, syringe was given chance to warm up a bit) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  On 06 Aug 2021 at 2:15pm, the patient received after being expired.  No treatment information was provided.
I have filler in my face and vaccine making it swelled; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on 01Apr2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation.  The patient medical history was not reported.  The patient's concomitant medications were not reported. The patient stated "I had the Pfizer, the first Pfizer vaccine. I have filler in my face and it's swelling with the filler one. It's not an Emergency." on an unspecified date with outcome of unknown.    No follow-up attempts are possible; information about lot/batch number cannot be obtained.
MMR and varicella immunization administered 10/14/02. Pt developed hives at varicella site immediately. These remained localized. Hives resolved in 24 hrs. Had a temp of 99 that evening. Did well until 10/31/02. At the varicella site had erythema. This developed into grouped vesicles on erythematous base. Eruption remained localized. No fever, mild fussiness. Lesions crusted in 5-6 days.
Extreme fatigue, pain in neck & left shoulder, red eyes, burning eyes, fever (low grade), flushing.
pt recv vax & pt devel a fever, irritability & soreness & pain @ the inj site;
Tingling in her left arm and leg; tested positive 2 weeks ago; This is a spontaneous report from contactable consumer (reported for herself) via Pfizer sponsored program COVAX US support.  The female patient of an unspecified age received first dose of BNT162B2 (Pfizer Covid-19 vaccine, solution for injection, Lot number: unknown) via an unspecified route of administration on 24Apr2021 Saturday, as a single dose for Covid-19 immunization. The patient's medical history and concomitant medications were not reported. Two weeks ago, she was tested positive for Covid. On the day of this report, she started noticing more tingling in her left arm and leg. The outcome of the events of positive for Covid and more tingling in her left arm and leg was not reported.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
t104.4 on & off x 6 days p/vax;inc temp assoc w/irritability, unconsolable crying;PE nl;
Presented with SOB/hypoxia, covid + 9/18; admitted to ICU with Covid PNA, sepsis; tx with HFO2, maxipime, steroids, remdesivir, actemra, merrem, ; intubated 9/24; on mulitple pressors; family requested DNR and Withdrawal of Care 10/1;
Swelling of right upper arm, painful, warm to the touch. Also has pain into the neck. Hard "ball" in the upper arm at site of vaccination
4.02.21 Patient reported that she developed a rash that she believes associated with the Pfizer vaccine.  She got the Pfizer vaccine on 3.31.21 at 6:15pm on the left deltoid.  According to her, she developed the rash on the left elbow on Thursday 4.01.2021 at 2am.  She took Xyzal and noticed the rash resolved.  On 4.02.21, she woke with a rash on the back of the right thigh and elbow.  She took cetirizine and the rash resolved.
Headache immediately upon injection. Tingling in arbs within first 2 minutes. Subsided after 10 minutes. It continued to come and go all day. Tongue tingling and swelling at 30 min mark. Took Benadryl after one hour of onset swelling.   As of 24 hours post vacc, some tingling and swelling is still present.
PT received influenza vaccine on 24 Oct 2017 around 1300 and states that she developed symptoms of swelling in her eyes on 25 Oct 2017 in both eyes. PT was treated at ER with Ranitidine 150 mg, Prednisone 50 mg, and Hydroxyzine 25 mg.
On Wednesday 8/22/12, arm vaccine was administered in became very red, swollen, itchy, & hot to the touch. Patient visited MD and was prescribed antibiotic.
expired Tenivac was administered to a patient, no adverse event; Initial information received on 30-Mar-2020 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 63 years old female patient who vaccinated with an expired dose of DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT [TENIVAC] (expired product administered).  The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided.  No concomitant medication was received.   On 29-Mar-2020, the patient received a 0.5 ml dose of suspect DIPHTHERIA-2/TETANUS-5 ADSORBED TOXOIDS NO PRESERVATIVE ADULT (lot number U5854AA, expiry date:25-Jan-2020) via intramuscular route in the left deltoid as prophylactic vaccination.  It was an actual medication error case due to expired vaccine used.  No adverse event reported at the time of reporting.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive and Module VI of the Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
shortness of oxygen; headaches; positive Covid test; loss of taste; loss of smell; head congestion; throat hurt; fatigue; This spontaneous case was reported by a patient and describes the occurrence of OROPHARYNGEAL PAIN (throat hurt), HEAD DISCOMFORT (head congestion), AGEUSIA (loss of taste), ANOSMIA (loss of smell) and COVID-19 (positive Covid test) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fatigue. Concomitant products included LEVOTHYROXINE for an unknown indication.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Feb-2021, the patient experienced FATIGUE (fatigue). On 26-Feb-2021, the patient experienced OROPHARYNGEAL PAIN (throat hurt). On 27-Feb-2021, the patient experienced HEAD DISCOMFORT (head congestion). On 02-Mar-2021, the patient experienced AGEUSIA (loss of taste) and ANOSMIA (loss of smell). On 03-Mar-2021, the patient experienced COVID-19 (positive Covid test). On 08-Mar-2021, the patient experienced HEADACHE (headaches). On 18-Mar-2021, the patient experienced DYSPNOEA (shortness of oxygen). On 27-Feb-2021, OROPHARYNGEAL PAIN (throat hurt) had resolved. On 13-Mar-2021, HEAD DISCOMFORT (head congestion) had resolved. At the time of the report, AGEUSIA (loss of taste) and COVID-19 (positive Covid test) was resolving, ANOSMIA (loss of smell), DYSPNOEA (shortness of oxygen) and HEADACHE (headaches) had not resolved and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication was reported.
Starting 05/08/2022 I had chills. The next day the chills continued and I developed body aches. On 05/09/2022, I tested positive for COVID. I had a telemedicine visit with urgent care due to risk factors for a severe case of COVID to discuss Paxlovid. On 05/10/2022, I started the Paxlovid. During the next 2 days, I had some body aches, some sinus pressure and some fatigue. I tested negative on 05/14/2022 and I finished Paxlovid on 05/15/2022. The following week I had more fatigue and shortness of breath and mild chest pain. I believe the chest pain and shortness of breath was due to the Paxlovid irritating my acid reflux. On 05/19/2022, I saw my doctor and they did an EKG and told me to see a cardiologist and do a chest x ray. I have had the chest x ray and will follow up to see the cardiologist. The shortness of breath and the mild chest pain has resolved.
Sudden onset of "excruciating" pain in right (injn) arm, shouder and infra-axillary region lasting for 2 hours. Took 1000 mg Tylenol, po. This was followed by "soreness" of right arm and restricted painful movements for another 48 hours. Examination at 11:35 AM 10/01/2009 - no erythema or swelling at inj. site. 1/4 tenderness medial to injection site over deltoid muscle and restricted abduction and external rotation of shoulder jt. neurological exam - WNL.   11:20 AM 10/05/2009 PE - WNL.
Developed hives all over left arm where injection was given. Took antihistamine & used cold compresses.
right arm is red; right arm is swollen; had fever all day; This case was reported by a consumer via  interactive digital media and described the occurrence of erythema of extremities in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles.   On 19th November 2021, the patient received Shingles vaccine. In November 2021, less than a week after receiving Shingles vaccine, the patient experienced erythema of extremities, swelling arm and fever. On an unknown date, the outcome of the erythema of extremities, swelling arm and fever were not recovered/not resolved.   It was unknown if the reporter considered the erythema of extremities, swelling arm and fever to be related to Shingles vaccine.  Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The patient had shingles over left eye.  The patient took Shingles shot yesterday from the day of reporting.  The patient's right arm was red and swollen and had fever all day, also said that hope tomorrow would better. No contact details were available. Note according to patient sequence of talking shingles over left eye was captured as historical condition.
Cellulitis L thigh - fever 101.7 given Rx Keflex 5/1/09. Seen in office 5/7/09 - given Rx for Omnicef. Flu office visit in 1 week.
So dizzy that felt like passing out; Sick to her stomach; Diarrhea; Fast rapid heart beat; Couldn't move; Could breathe but not right; Lymph nodes on both sides of her neck swollen; Vomiting; Massive headache; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (So dizzy that felt like passing out), ABDOMINAL DISCOMFORT (Sick to her stomach), DIARRHOEA (Diarrhea), PALPITATIONS (Fast rapid heart beat) and HYPOKINESIA (Couldn't move) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 039A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Cancer (Patient is on remission from cancer for the third time.) and Heart attack (Patient reported having several heart attacks in the past.). Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), LEVOTHYROXINE SODIUM (LEVOXYL), CARVEDILOL and LOVASTATIN for an unknown indication.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Apr-2021, the patient experienced DIZZINESS (So dizzy that felt like passing out), ABDOMINAL DISCOMFORT (Sick to her stomach), DIARRHOEA (Diarrhea), PALPITATIONS (Fast rapid heart beat), HYPOKINESIA (Couldn't move), DYSPNOEA (Could breathe but not right), LYMPHADENOPATHY (Lymph nodes on both sides of her neck swollen), VOMITING (Vomiting) and HEADACHE (Massive headache). The patient was treated with IBUPROFEN at an unspecified dose and frequency. On 13-Apr-2021, DIZZINESS (So dizzy that felt like passing out) and HYPOKINESIA (Couldn't move) had resolved. At the time of the report, ABDOMINAL DISCOMFORT (Sick to her stomach), LYMPHADENOPATHY (Lymph nodes on both sides of her neck swollen), VOMITING (Vomiting) and HEADACHE (Massive headache) outcome was unknown, DIARRHOEA (Diarrhea) and PALPITATIONS (Fast rapid heart beat) had not resolved and DYSPNOEA (Could breathe but not right) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Vomiting on 9/11/04. Diarrhea on 9/12/04. Four seizures on 9/13/04. Required hospitalization for 2 days. She had a brain wave test, CT Scan, blood work and spinal tap which all came back clear. Now she is on phenobarbital.  Nurse follow up on 11/01/04 states: "Groggy; Eyes flutter; Lip smacking; Perioral cyanosis; Diarrhea."
Received J&J Covid vaccine in left shoulder--no blood after needle or next day upon removing bandaid.  After 15 min observation period, felt tingling and numbness in left hand fingers.  As I drove home, numbness and tingling moved to the left side of my head, changing nerve feelings randomly from ear, to cheek, to jaw, to gums.  These symptoms were told to be expected, and thankfully greatly diminished upon awaking the next morning, although still not 100% gone a few days later.  Also, upon going to bed, would feel random crawling feelings on ears, face and scalp.  Side effect that was reported to be potentially serious in waiver was unusual bruishing.   24-36 hours after shot, I noticed red horse shoe shaped squiggle on inside of left bicep.  No overly tender and could not feel bumps.  Turned to bruise.  Followed literature side effect precaution so returned to clinic on Monday afternoon and was given neurological tests by provider.  At this time, I just hope no further symptoms present and experience dissapates as literature indicates should occur.
Caller and his wife received the 1st dose of the Moderna vaccine on 23July2021 and got Covid-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Caller and his wife received the 1st dose of the Moderna vaccine on 23July2021 and got Covid-19) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (Caller and his wife received the 1st dose of the Moderna vaccine on 23July2021 and got Covid-19). At the time of the report, COVID-19 (Caller and his wife received the 1st dose of the Moderna vaccine on 23July2021 and got Covid-19) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   No concomitant and treatment medication was reported by patient.  Patient reported that she was scheduled to receive the 2 dose on 20-Aug-2021 but her doctor told her to wait 90 days after her symptoms gone. Patient have not received 2 dose yet.   This case was linked to MOD-2021-294324 (Patient Link).
about 1 wk p/receiving MMR vax; pt noted small, tender nodules in suboccipital & postaoricular areas bilaterally, also pain in rt TMJ, aching in eyes on lateral gaze; exam 2APR93 shows t99 & confirms suboccipital & postauricular lymphaden